NPS MedicineWise: Quality Use of Medicines and Clinical Resources
NPS MedicineWise provides health professionals with timely, independent and evidence-based information for Australian health professionals and consumers. This initiative focuses on improving clinical practice and health outcomes for Australia by helping Australians make better decisions about medicines, medical tests and other health technologies.
Clinical Programs and Professional Development
Our new and ongoing programs for healthcare professionals are designed to provide relevant, timely and evidence-based information. These include:
- bDMARDs: Making safe and wise decisions for biological disease-modifying antirheumatic drugs (bDMARDs) and other specialised medicines.
- MedicineInsight: Improving clinical practice and health outcomes for Australia.
- Choosing Wisely: Provides health professionals with practical information, tools and resources to help improve the quality of health care and safety for patients.
- Quality Improvement Hub: Practical information and tools for health professionals and staff to help improve the quality of health care.
Featured Health Topics and Resources
NPS MedicineWise offers featured topics and resources to empower and engage both professionals and consumers:
- Chronic kidney disease: a focus on early detection and management.
- Mental health and young people: opportunities to empower and engage.
- Pain management hub: relevant tools and resources for managing pain.
- Benzodiazepine dependence: strategies to reduce the risk.
Consumer Medicine Information: MS-2 Step
MS-2 Step is a composite pack product containing Mifepristone Linepharma 200 mg tablet and GyMiso misoprostol 200 microgram tablets. MS-2 Step Mifepristone Linepharma contains the active ingredient mifepristone.
Indications for Use
MS-2 Step Mifepristone Linepharma is used to terminate a pregnancy up to 63 days after your last menstrual period when used in combination with MS-2 Step GyMiso.
Important Safety Information
WARNING: Important safety information is provided in a boxed warning in the full CMI. Read before using this medicine. If you are worried about using this medicine, speak to your healthcare practitioner (doctor, nurse or pharmacist). Do not use if you have ever had an allergic reaction to mifepristone or any of the ingredients listed at the end of the CMI.
Talk to your healthcare practitioner if you have any other medical conditions, take any other medicines, or are pregnant or plan to become pregnant.
Popular Medicine Information Searches
The following categories and active ingredients are frequently accessed for medication safety and health info:
- Medication safety: Aspirin, Paracetamol, and Warfarin.
- Chronic conditions: Metformin for diabetes and Metoprolol.
- General health: Antibiotic use and drug information.